The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 12, 2019
Tocagen announced the Phase 3 trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) undergoing resection missed the ...
read more
Thursday, September 12, 2019
GT Biopharma has notified FDA that it was commencing enrollment in its first-in-human GTB-3550 Phase I/II clinical trial.
read more
Thursday, September 12, 2019
Moderna announced positive data in the first analysis of safety and activity in its study evaluating escalating doses of mRNA-1944 administered via ...
read more
Monday, September 16, 2019
Seattle Genetics and Astellas announced the FDA has accepted the BLA for the investigational agent enfortumab vedotin for locally advanced or ...
read more
Wednesday, September 18, 2019
Pulmatrix announced the first patient has been dosed in the Phase 2 trial evaluating Pulmazole for Allergic Bronchopulmonary Aspergillosis (ABPA) in ...
read more
Thursday, September 19, 2019
Trovagene announced the successful completion of its Phase 1b trial of onvansertib in combination with standard-of-care chemotherapy in AML and ...
read more
Friday, September 20, 2019
The FDA approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and ...
read more
Friday, September 20, 2019
Reneo announced the FDA Office of Orphan Products Development has granted Orphan Drug Designation to REN001 for the treatment of fatty acid oxidation ...
read more
Monday, September 23, 2019
Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving ...
read more
Monday, September 23, 2019
Amydis has received a Phase 2A SBIR grant award from the National Institute on Aging of the National Institutes of Health (NIH).
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat ...
read more
Tuesday, September 24, 2019
Over the past few years we’ve witnessed new medical breakthroughs that are altering how diseases are treated in ways that seemed unimaginable just a ...
read more
Wednesday, September 25, 2019
The FDA announced the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease ...
read more
Thursday, September 26, 2019
Galmed Pharmaceuticals announced the initiation of its Phase 3/4 ARMOR clinical study to evaluate the efficacy and safety of Aramchol in subjects with...
read more
Friday, September 27, 2019
89bio has initiated dosing in its proof of concept Phase 1b/2a clinical trial evaluating its product candidate, BIO89-100, in patients with NASH or ...
read more